-
1
-
-
34548237585
-
Microtubule polymerization: One step at a time
-
10.1016/j.cub.2007.07.002. 17803927
-
Microtubule polymerization: one step at a time. D Sept, Curr Biol 2007 17 764 766 10.1016/j.cub.2007.07.002 17803927
-
(2007)
Curr Biol
, vol.17
, pp. 18764-766
-
-
Sept, D.1
-
2
-
-
0025153023
-
Kinetochores capture astral microtubules during chromosome attachment to the mitotic spindle: Direct visualization in live newt lung cells
-
10.1083/jcb.111.3.1039. 2391359
-
Kinetochores capture astral microtubules during chromosome attachment to the mitotic spindle: direct visualization in live newt lung cells. JH Hayden SS Bowser CL Rieder, J Cell Biol 1990 111 1039 1045 10.1083/jcb.111.3.1039 2391359
-
(1990)
J Cell Biol
, vol.111
, pp. 1039-1045
-
-
Hayden, J.H.1
Bowser, S.S.2
Rieder, C.L.3
-
3
-
-
9144254574
-
Microtubulin binding sites as target for developing anticancer agents
-
15579115
-
Microtubulin binding sites as target for developing anticancer agents. MN Islam MN Iskander, Mini Rev Med Chem 2004 4 1077 1104 15579115
-
(2004)
Mini Rev Med Chem
, vol.4
, pp. 1077-1104
-
-
Islam, M.N.1
Iskander, M.N.2
-
4
-
-
0025333168
-
Taxol: A novel investigational antimicrotubule agent
-
10.1093/jnci/82.15.1247. 1973737
-
Taxol: a novel investigational antimicrotubule agent. EK Rowinsky LA Cazenave RC Donehower, J Natl Cancer Inst 1990 82 1247 1259 10.1093/jnci/82.15. 1247 1973737
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 1247-1259
-
-
Rowinsky, E.K.1
Cazenave, L.A.2
Donehower, R.C.3
-
5
-
-
0026345003
-
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
-
10.1016/0163-7258(91)90086-2. 1687171
-
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. EK Rowinsky RC Donehower, Pharmacol Ther 1991 52 35 84 10.1016/0163-7258(91)90086-2 1687171
-
(1991)
Pharmacol Ther
, vol.52
, pp. 35-84
-
-
Rowinsky, E.K.1
Donehower, R.C.2
-
6
-
-
4544381708
-
Regulation of Bax activation and apoptotic response to microtubule-damaging agents by p53 transcription-dependent and -independent pathways
-
10.1074/jbc.M401530200. 15262986
-
Regulation of Bax activation and apoptotic response to microtubule-damaging agents by p53 transcription-dependent and -independent pathways. H Yamaguchi J Chen K Bhalla HG Wang, J Biol Chem 2004 279 39431 39437 10.1074/jbc.M401530200 15262986
-
(2004)
J Biol Chem
, vol.279
, pp. 39431-39437
-
-
Yamaguchi, H.1
Chen, J.2
Bhalla, K.3
Wang, H.G.4
-
7
-
-
33744907775
-
Vinblastine-induced apoptosis is mediated by discrete alterations in subcellular location, oligomeric structure, and activation status of specific Bcl-2 family members
-
10.1074/jbc.M512586200. 16574665
-
Vinblastine-induced apoptosis is mediated by discrete alterations in subcellular location, oligomeric structure, and activation status of specific Bcl-2 family members. M Upreti CS Lyle B Skaug L Du TC Chambers, J Biol Chem 2006 281 15941 15950 10.1074/jbc.M512586200 16574665
-
(2006)
J Biol Chem
, vol.281
, pp. 15941-15950
-
-
Upreti, M.1
Lyle, C.S.2
Skaug, B.3
Du, L.4
Chambers, T.C.5
-
8
-
-
84988112944
-
Antibiotics from gliding bacteria, LIX: Disorazoles, highly cytotoxic metabolites from the sorangicin-producing bacterium sorangium cellulosum strain
-
Antibiotics from gliding bacteria, LIX: Disorazoles, highly cytotoxic metabolites from the sorangicin-producing bacterium sorangium cellulosum strain. RIH Jansen H Reichenbach V Wray G Höfle, Liebigs Annalen der Chemie 1994 8
-
(1994)
Liebigs Annalen der Chemie
, vol.8
-
-
Jansen, R.I.H.1
Reichenbach, H.2
Wray, V.3
Höfle, G.4
-
9
-
-
1042263998
-
Disorazol A1, a highly effective antimitotic agent acting on tubulin polymerization and inducing apoptosis in mammalian cells
-
10.1016/j.bcp.2003.10.029. 15104246
-
Disorazol A1, a highly effective antimitotic agent acting on tubulin polymerization and inducing apoptosis in mammalian cells. YA Elnakady F Sasse H Lunsdorf H Reichenbach, Biochem Pharmacol 2004 67 927 935 10.1016/j.bcp.2003.10. 029 15104246
-
(2004)
Biochem Pharmacol
, vol.67
, pp. 927-935
-
-
Elnakady, Y.A.1
Sasse, F.2
Lunsdorf, H.3
Reichenbach, H.4
-
10
-
-
9644258887
-
Total synthesis of (-)-disorazole C1
-
10.1021/ja0443068. 15563138
-
Total synthesis of (-)-disorazole C1. P Wipf TH Graham, J Am Chem Soc 2004 126 15346 15347 10.1021/ja0443068 15563138
-
(2004)
J Am Chem Soc
, vol.126
, pp. 15346-15347
-
-
Wipf, P.1
Graham, T.H.2
-
11
-
-
33745112858
-
Cellular analysis of disorazole C and structure-activity relationship of analogs of the natural product
-
10.1111/j.1747-0285.2005.00313.x. 16492150
-
Cellular analysis of disorazole C and structure-activity relationship of analogs of the natural product. P Wipf TH Graham A Vogt RP Sikorski AP Ducruet JS Lazo, Chem Biol Drug Des 2006 67 66 73 10.1111/j.1747-0285.2005.00313.x 16492150
-
(2006)
Chem Biol Drug des
, vol.67
, pp. 66-73
-
-
Wipf, P.1
Graham, T.H.2
Vogt, A.3
Sikorski, R.P.4
Ducruet, A.P.5
Lazo, J.S.6
-
12
-
-
62449223586
-
Microtubule binding and disruption and induction of premature senescence by disorazole C1
-
10.1124/jpet.108.147330
-
Microtubule binding and disruption and induction of premature senescence by disorazole C1. MB Tierno CA Kitchens B Petrik TH Graham P Wipf F Xu W Saunders BS Raccor R Balachandran BW Day JR Stout CE Walczak AP Ducruet CE Reese JS Lazo, J Pharmacol Exp Ther 2009 28 715 22 10.1124/jpet.108.147330
-
(2009)
J Pharmacol Exp Ther
, vol.28
, pp. 715-22
-
-
Tierno, M.B.1
Kitchens, C.A.2
Petrik, B.3
Graham, T.H.4
Wipf, P.5
Xu, F.6
Saunders, W.7
Raccor, B.S.8
Balachandran, R.9
Day, B.W.10
Stout, J.R.11
Walczak, C.E.12
Ducruet, A.P.13
Reese, C.E.14
Lazo, J.S.15
-
13
-
-
0028070358
-
Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase
-
7913875
-
Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. BH Long CR Fairchild, Cancer Res 1994 54 4355 4361 7913875
-
(1994)
Cancer Res
, vol.54
, pp. 4355-4361
-
-
Long, B.H.1
Fairchild, C.R.2
-
14
-
-
0032031453
-
Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid
-
10.1016/S0006-2952(97)00505-4. 9515574
-
Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid. A Kruczynski JM Barret C Etievant F Colpaert J Fahy BT Hill, Biochem Pharmacol 1998 55 635 648 10.1016/S0006-2952(97)00505-4 9515574
-
(1998)
Biochem Pharmacol
, vol.55
, pp. 635-648
-
-
Kruczynski, A.1
Barret, J.M.2
Etievant, C.3
Colpaert, F.4
Fahy, J.5
Hill, B.T.6
-
15
-
-
9644258011
-
Paclitaxel induces primary and postmitotic G1 arrest in human arterial smooth muscle cells
-
15254417
-
Paclitaxel induces primary and postmitotic G1 arrest in human arterial smooth muscle cells. MV Blagosklonny Z Darzynkiewicz HD Halicka P Pozarowski ZN Demidenko JJ Barry KR Kamath RA Herrmann, Cell Cycle 2004 3 1050 1056 15254417
-
(2004)
Cell Cycle
, vol.3
, pp. 1050-1056
-
-
Blagosklonny, M.V.1
Darzynkiewicz, Z.2
Halicka, H.D.3
Pozarowski, P.4
Demidenko, Z.N.5
Barry, J.J.6
Kamath, K.R.7
Herrmann, R.A.8
-
16
-
-
33744996707
-
Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint
-
10.1016/j.cub.2006.04.043. 16782009
-
Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. DA Brito CL Rieder, Curr Biol 2006 16 1194 1200 10.1016/j.cub.2006.04.043 16782009
-
(2006)
Curr Biol
, vol.16
, pp. 1194-1200
-
-
Brito, D.A.1
Rieder, C.L.2
-
17
-
-
0035804223
-
Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner
-
10.1038/sj.onc.1204060. 11244509
-
Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner. ZA Stewart LJ Tang JA Pietenpol, Oncogene 2001 20 113 124 10.1038/sj.onc.1204060 11244509
-
(2001)
Oncogene
, vol.20
, pp. 113-124
-
-
Stewart, Z.A.1
Tang, L.J.2
Pietenpol, J.A.3
-
18
-
-
33846584645
-
Mitotic arrest and cell fate: Why and how mitotic inhibition of transcription drives mutually exclusive events
-
17245109
-
Mitotic arrest and cell fate: why and how mitotic inhibition of transcription drives mutually exclusive events. MV Blagosklonny, Cell Cycle 2007 6 70 74 17245109
-
(2007)
Cell Cycle
, vol.6
, pp. 70-74
-
-
Blagosklonny, M.V.1
-
19
-
-
0345275866
-
Gene expression and mitotic exit induced by microtubule-stabilizing drugs
-
14633718
-
Gene expression and mitotic exit induced by microtubule-stabilizing drugs. JG Chen CP Yang M Cammer SB Horwitz, Cancer Res 2003 63 7891 7899 14633718
-
(2003)
Cancer Res
, vol.63
, pp. 7891-7899
-
-
Chen, J.G.1
Yang, C.P.2
Cammer, M.3
Horwitz, S.B.4
-
20
-
-
0042704723
-
Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints
-
12824307
-
Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints. R Warrener H Beamish A Burgess NJ Waterhouse N Giles D Fairlie B Gabrielli, Faseb J 2003 17 1550 1552 12824307
-
(2003)
Faseb J
, vol.17
, pp. 1550-1552
-
-
Warrener, R.1
Beamish, H.2
Burgess, A.3
Waterhouse, N.J.4
Giles, N.5
Fairlie, D.6
Gabrielli, B.7
-
21
-
-
22244459880
-
Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage
-
10.1016/j.ccr.2005.06.003. 16023598
-
Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. W Tao VJ South Y Zhang JP Davide L Farrell NE Kohl L Sepp-Lorenzino RB Lobell, Cancer Cell 2005 8 49 59 10.1016/j.ccr.2005.06.003 16023598
-
(2005)
Cancer Cell
, vol.8
, pp. 49-59
-
-
Tao, W.1
South, V.J.2
Zhang, Y.3
Davide, J.P.4
Farrell, L.5
Kohl, N.E.6
Sepp-Lorenzino, L.7
Lobell, R.B.8
-
22
-
-
0032883001
-
Molecular effects of paclitaxel: Myths and reality (a critical review)
-
10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5. 10471519
-
Molecular effects of paclitaxel: myths and reality (a critical review). MV Blagosklonny T Fojo, Int J Cancer 1999 83 151 156 10.1002/(SICI)1097- 0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5 10471519
-
(1999)
Int J Cancer
, vol.83
, pp. 151-156
-
-
Blagosklonny, M.V.1
Fojo, T.2
-
24
-
-
40449137094
-
CDC20, a potential cancer therapeutic target, is negatively regulated by p53
-
10.1038/sj.onc.1210799. 17873905
-
CDC20, a potential cancer therapeutic target, is negatively regulated by p53. T Kidokoro C Tanikawa Y Furukawa T Katagiri Y Nakamura K Matsuda, Oncogene 2008 27 1562 1571 10.1038/sj.onc.1210799 17873905
-
(2008)
Oncogene
, vol.27
, pp. 1562-1571
-
-
Kidokoro, T.1
Tanikawa, C.2
Furukawa, Y.3
Katagiri, T.4
Nakamura, Y.5
Matsuda, K.6
-
25
-
-
34247333444
-
The spindle-assembly checkpoint in space and time
-
10.1038/nrm2163. 17426725
-
The spindle-assembly checkpoint in space and time. A Musacchio ED Salmon, Nat Rev Mol Cell Biol 2007 8 379 393 10.1038/nrm2163 17426725
-
(2007)
Nat Rev Mol Cell Biol
, vol.8
, pp. 379-393
-
-
Musacchio, A.1
Salmon, E.D.2
-
26
-
-
0029972806
-
P53: Puzzle and paradigm
-
10.1101/gad.10.9.1054. 8654922
-
p53: puzzle and paradigm. LJ Ko C Prives, Genes Dev 1996 10 1054 1072 10.1101/gad.10.9.1054 8654922
-
(1996)
Genes Dev
, vol.10
, pp. 1054-1072
-
-
Ko, L.J.1
Prives, C.2
|